What are the primary mechanisms behind cardiac toxicity associated with Tricyclic antidepressants?
Which anxiolytic acts through 5-HT1A receptor partial agonism without exhibiting significant anticonvulsant or muscle relaxant properties?
Lithium directly affects which ion ?
Which of the following is a classic tricyclic antidepressant (TCA) commonly used as the prototype for the class?
Which of the following is a tricyclic antidepressant?
Visual field monitoring is important before starting which of the following drugs for epilepsy treatment?
Which of the following statements about lamotrigine is correct?
Which is a GABA transaminase inhibitor?
Most clinically significant side effect of topiramate requiring immediate medical attention?
What serious side effect may lead to the discontinuation of felbamate?
NEET-PG 2013 - Pharmacology NEET-PG Practice Questions and MCQs
Question 51: What are the primary mechanisms behind cardiac toxicity associated with Tricyclic antidepressants?
- A. Norepinephrine reuptake inhibition only
- B. Anticholinergic effects on the heart
- C. Both norepinephrine reuptake inhibition and anticholinergic effects on the heart (Correct Answer)
- D. Direct membrane stabilizing effects only
Explanation: ***Both norepinephrine reuptake inhibition and anticholinergic effects on the heart*** - **Tricyclic antidepressants (TCAs)** block the reuptake of **norepinephrine**, which can lead to increased sympathetic tone on the heart and potentially **tachyarrhythmias** or other cardiac complications. - TCAs also have potent **anticholinergic effects**, blocking muscarinic receptors in the heart; this can increase **heart rate** and affect cardiovascular stability. - While **direct membrane stabilizing effects** (sodium channel blockade) are critical for **QRS widening and conduction delays**, the combination of norepinephrine reuptake inhibition and anticholinergic effects accounts for the broader spectrum of **TCA-induced cardiac toxicity** including tachycardia and hemodynamic instability. *Norepinephrine reuptake inhibition only* - While TCAs do inhibit norepinephrine reuptake contributing to tachycardia and increased sympathetic tone, this mechanism alone does not fully explain the breadth of cardiac effects seen with these drugs. - The **anticholinergic effects** play a significant additional role in altering cardiac function. *Anticholinergic effects on the heart* - While TCAs do exert anticholinergic effects that can impact heart rate and cardiovascular function, this mechanism alone fails to account for the additional contributions from **norepinephrine reuptake inhibition** to the overall cardiac toxicity. - The combination of both mechanisms is necessary for a complete understanding of **TCA-induced cardiac effects**. *Direct membrane stabilizing effects only* - This option refers to the **quinidine-like action** of TCAs, which involves blocking myocardial fast sodium channels, leading to a **prolonged QRS interval** and increased risk of **ventricular arrhythmias** and **conduction defects**. - While direct membrane stabilization is the **primary mechanism of TCA-induced conduction abnormalities** (QRS widening, heart blocks), the question asks for mechanisms of broader **cardiac toxicity**, which includes the combined effects of norepinephrine reuptake inhibition and anticholinergic actions on heart rate and hemodynamics.
Question 52: Which anxiolytic acts through 5-HT1A receptor partial agonism without exhibiting significant anticonvulsant or muscle relaxant properties?
- A. Diazepam
- B. Zolpidem
- C. Phenobarbitone
- D. Buspirone (Correct Answer)
Explanation: ***Buspirone*** - **Buspirone** is a unique anxiolytic that primarily acts as a **partial agonist at 5-HT1A receptors**. - Unlike benzodiazepines, it lacks significant **anticonvulsant**, **muscle relaxant**, or **sedative-hypnotic properties** and does not lead to physical dependence or withdrawal. *Diazepam* - **Diazepam** is a **benzodiazepine** that acts by enhancing the effect of **GABA** at GABA-A receptors, leading to significant anxiolytic, sedative, muscle relaxant, and anticonvulsant effects. - It does not primarily act via **5-HT1A receptor partial agonism**. *Zolpidem* - **Zolpidem** is a **non-benzodiazepine hypnotic** that selectively binds to the **GABA-A receptor** subunit, primarily mediating sedative effects. - While it's used for insomnia, it doesn't primarily act as a **5-HT1A partial agonist** and is not typically used for its anxiolytic properties in the same way as buspirone. *Phenobarbitone* - **Phenobarbitone** is a **barbiturate** that acts by prolonging the opening of **chloride channels** associated with GABA-A receptors, leading to strong sedative, hypnotic, and anticonvulsant effects. - Its mechanism of action is distinct from **5-HT1A receptor partial agonism**, and it carries a high risk of dependence and overdose.
Question 53: Lithium directly affects which ion ?
- A. Sodium (Correct Answer)
- B. Potassium
- C. Magnesium
- D. Calcium
Explanation: ***Sodium*** - Lithium directly interferes with **sodium ion transport** across cell membranes, particularly by inhibiting the **Na+/K+-ATPase** pump. - This interference alters intracellular sodium concentrations and affects neural excitability, contributing to its **mood-stabilizing** effects. *Potassium* - While potassium transport is linked to the **Na+/K+-ATPase pump**, lithium primarily acts through its effect on **sodium transport**, rather than directly mimicking or significantly altering potassium. - Changes in potassium levels due to lithium are largely secondary to its primary impact on sodium. *Magnesium* - Lithium has a more direct impact on **sodium channels** and transporters, contrasting with its less direct or significant interaction with magnesium metabolism. - Though magnesium is crucial for numerous cellular processes, it is not the primary ion directly affected by lithium's therapeutic actions. *Calcium* - Lithium does not directly affect **calcium channels** or calcium signaling pathways in the same way it impacts sodium. - While lithium may indirectly influence calcium-dependent processes, its primary direct target for therapeutic effects is not calcium.
Question 54: Which of the following is a classic tricyclic antidepressant (TCA) commonly used as the prototype for the class?
- A. Amitriptyline (Correct Answer)
- B. Citalopram
- C. Venlafaxine
- D. Nortriptyline
Explanation: ***Amitriptyline*** - **Amitriptyline** is a classic tricyclic antidepressant (TCA) and is widely recognized for its use in treating depression, neuropathic pain, and migraine prophylaxis. Its characteristic side effect profile, including **anticholinergic effects** and **sedation**, is well-known. - It is one of the **oldest and most frequently prescribed TCAs**, making it a common reference point in pharmacology and clinical practice. *Citalopram* - **Citalopram** is an **SSRI** (selective serotonin reuptake inhibitor), not a TCA. It works by selectively inhibiting the reuptake of serotonin. - It has a different side effect profile compared to TCAs, generally with fewer anticholinergic and cardiovascular effects. *Venlafaxine* - **Venlafaxine** is an **SNRI** (serotonin-norepinephrine reuptake inhibitor), not a TCA. It inhibits the reuptake of both serotonin and norepinephrine. - It has efficacy in treating depression and anxiety disorders, but its mechanism of action is distinct from TCAs. *Nortriptyline* - **Nortriptyline** is indeed a TCA, specifically a **secondary amine TCA**, which is an active metabolite of amitriptyline. - While it is a TCA, amitriptyline is generally more broadly recognized and used as the prototype for the class, with nortriptyline often being highlighted for its slightly better tolerability profile (e.g., less sedation, less orthostatic hypotension) compared to tertiary amine TCAs like amitriptyline.
Question 55: Which of the following is a tricyclic antidepressant?
- A. Fluoxetine
- B. Citalopram
- C. Doxepin (Correct Answer)
- D. Venlafaxine
Explanation: ***Doxepin*** - **Doxepin** is a **tricyclic antidepressant (TCA)** that inhibits the reuptake of **serotonin** and **norepinephrine**, and also has significant **histaminergic** and **cholinergic** blocking effects. - TCAs, including doxepin, are commonly used for treating **depression**, **anxiety**, and certain pain conditions. *Venlafaxine* - **Venlafaxine** is a **serotonin-norepinephrine reuptake inhibitor (SNRI)**, not a tricyclic antidepressant. - SNRIs selectively block the reuptake of both **serotonin** and **norepinephrine**, but lack the broad receptor affinity of TCAs. *Fluoxetine* - **Fluoxetine** is a **selective serotonin reuptake inhibitor (SSRI)**, which specifically targets serotonin reuptake. - SSRIs are generally considered a first-line treatment for depression due to a more favorable side effect profile compared to TCAs. *Citalopram* - **Citalopram** is also a **selective serotonin reuptake inhibitor (SSRI)**, much like fluoxetine. - It works by increasing the levels of **serotonin** in the brain by blocking its reuptake, differentiating it from tricyclic antidepressants.
Question 56: Visual field monitoring is important before starting which of the following drugs for epilepsy treatment?
- A. Vigabatrin (Correct Answer)
- B. Topiramate
- C. Valproic acid
- D. Carbamazepine
Explanation: ***Vigabatrin*** - **Vigabatrin** is known to cause **irreversible concentric visual field constriction** (peripheral vision loss) due to retinal toxicity. - Regular **ophthalmological monitoring**, including **visual field testing**, is crucial before and during treatment to detect and manage this adverse effect early. *Topiramate* - Topiramate can cause **acute angle-closure glaucoma** and **myopia**, which affect vision, but regular visual field monitoring is not a primary requirement for this specific side effect. - Its main concerns often relate to cognitive side effects and kidney stones, rather than progressive visual field loss requiring baseline and ongoing field testing. *Valproic acid* - Valproic acid is not typically associated with specific visual field defects requiring routine monitoring. - Its major side effects often involve **hepatotoxicity**, **pancreatitis**, and **teratogenicity**. *Carbamazepine* - Carbamazepine's notable side effects include **aplastic anemia**, **hyponatremia**, and **Stevens-Johnson syndrome**. - While it can cause some ocular side effects like **diplopia** or **nystagmus**, it does not typically lead to the progressive and irreversible visual field constriction seen with vigabatrin, which necessitates strict monitoring.
Question 57: Which of the following statements about lamotrigine is correct?
- A. Is the first choice for absence seizures.
- B. Has a half-life of approximately 24 hours. (Correct Answer)
- C. Is not significantly metabolized in the liver.
- D. Has decreased efficacy in treating depressive episodes.
Explanation: ***Has a half-life of approximately 24 hours.*** - Lamotrigine's **half-life** is typically around **24 to 33 hours** in adults, which allows for once or twice-daily dosing. - This relatively long half-life is advantageous for maintaining **stable plasma concentrations** and improving patient adherence. *Is the first choice for absence seizures.* - **Ethosuximide** or **valproate** are generally considered first-line treatments for **absence seizures**. - Lamotrigine is not the preferred initial therapy due to its **slower titration** and occasional lack of efficacy in this seizure type. *Is not significantly metabolized in the liver.* - Lamotrigine is **significantly metabolized** in the liver, primarily through **glucuronidation** by the **UGT1A4 enzyme**. - This hepatic metabolism explains many of its **drug interactions**, particularly with other antiepileptic drugs affecting UGT enzymes. *Has decreased efficacy in treating depressive episodes.* - Lamotrigine is known for its **mood-stabilizing properties** and is effective in treating and preventing **depressive episodes**, particularly in **bipolar disorder**. - Its efficacy in depression is a key distinguishing feature, making it a valuable option for patients with comorbid mood disorders.
Question 58: Which is a GABA transaminase inhibitor?
- A. TCA
- B. Valproate (Correct Answer)
- C. Gabapentin
- D. Sertraline
Explanation: ***Valproate*** - Valproate is known to inhibit **GABA transaminase**, an enzyme responsible for the breakdown of **gamma-aminobutyric acid (GABA)**. - By inhibiting this enzyme, valproate increases the concentration of **GABA** in the brain, enhancing its inhibitory effects and contributing to its anticonvulsant properties. *TCA* - **Tricyclic antidepressants (TCAs)** primarily work by inhibiting the reuptake of **norepinephrine** and **serotonin** in the brain. - They do not directly inhibit GABA transaminase but rather modulate monoamine neurotransmission. *Sertraline* - **Sertraline** is a **selective serotonin reuptake inhibitor (SSRI)** that works by blocking the reabsorption of **serotonin** into presynaptic neurons. - Its primary mechanism of action is focused on serotonin pathways, not on GABA metabolism. *Gabapentin* - **Gabapentin** is an anticonvulsant that is thought to exert its effects by modulating **calcium channels** and increasing **GABA synthesis**, but it is not a direct inhibitor of GABA transaminase. - Its mechanism of action is distinct from directly preventing GABA breakdown.
Question 59: Most clinically significant side effect of topiramate requiring immediate medical attention?
- A. Weight loss
- B. Visual impairment (Correct Answer)
- C. Insomnia
- D. Hemolysis
Explanation: ***Visual impairment*** - Topiramate can cause **acute angle-closure glaucoma**, a medical emergency that typically occurs within the **first month of therapy**. - Mechanism: Topiramate causes **ciliary body swelling** and **uveal effusion**, leading to anterior rotation of the iris-lens diaphragm and angle closure. - Clinical presentation: Rapid-onset **blurred vision**, **eye pain**, **headache**, **redness**, and may progress to permanent vision loss if untreated. - Management: **Immediate discontinuation** of topiramate and urgent **ophthalmology referral** for intraocular pressure management. *Weight loss* - Weight loss is a common and often desired side effect of topiramate, related to its effect on **appetite suppression** and enhanced satiety. - While it can be significant, it does not typically require immediate medical attention unless it becomes excessive or leads to nutritional deficiencies. - This side effect is sometimes therapeutically exploited in migraine prophylaxis. *Insomnia* - Insomnia is a known side effect of topiramate and can impact quality of life but is generally not life-threatening or an immediate medical emergency. - Management often involves adjusting the dosage, timing of administration (dosing earlier in the day), or prescribing sleep aids. *Hemolysis* - Hemolysis is **not a recognized side effect** of topiramate. - Topiramate is not known to directly cause the destruction of red blood cells. - Other serious side effects of topiramate include metabolic acidosis, kidney stones, and cognitive impairment, but not hemolysis.
Question 60: What serious side effect may lead to the discontinuation of felbamate?
- A. Seizures
- B. Renal impairment
- C. Gastrointestinal disorder
- D. Aplastic anemia (Correct Answer)
Explanation: ***Aplastic anemia*** - Felbamate is known to cause **aplastic anemia**, a severe and life-threatening condition where the **bone marrow stops producing enough new blood cells**. - Felbamate carries a **black box warning** for both aplastic anemia and **hepatotoxicity (severe liver failure)**, which are the two most serious adverse effects leading to discontinuation. - Due to this significant risk, felbamate is reserved for severe, refractory epilepsy cases, and patients require **regular monitoring** of blood counts and liver function tests. *Renal impairment* - While some medications can cause renal impairment, **felbamate is not primarily associated** with this side effect to the extent of requiring discontinuation. - Its metabolism and excretion are predominantly **hepatic (liver)**, and renal effects are less common or severe. *Gastrointestinal disorder* - Gastrointestinal side effects like nausea or vomiting are **common with many medications**, including felbamate, but are generally **mild and manageable**, rarely leading to discontinuation. - These effects are usually **dose-dependent** and can often be mitigated with supportive care. *Seizures* - Felbamate is an **antiepileptic drug (AED)**, so it is used to treat seizures, not cause them. - If a patient experiences seizures while on felbamate, it usually indicates **inadequate treatment response** or seizure exacerbation, rather than a direct side effect necessitating discontinuation for toxicity.